Skip to main content

Table 5 Dilution linearity of reduced hIL-33 endogenously expressed in human matrices

From: Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

Dilution factor in matrix Observed (pg/mL) Corrected (pg/mL) % Recovery
1:2 VH 3.44 6.87 110.7
1:4 VH 1.45 5.78 93.1
1:8 VH 0.75 5.98 96.2
1:2 AH 3.21 6.43 98.3
1:4 AH 1.66 6.65 101.7
1:2 serum 3.02 6.04 66.3
1:4 serum 2.24 8.94 98.2
1:10 serum 1.07 10.70 117.5
1:20 serum 0.54 10.75 118.0
1:2 plasma 4.77 9.55 96.4
1:4 plasma 2.79 11.14 112.5
1:10 plasma 1.03 10.27 103.7
1:20 plasma 0.43 8.64 87.3
1:2 NF 7.91 15.82 109.1
1:4 NF 3.94 15.77 108.7
1:10 NF 1.32 13.16 90.7
1:20 NF 0.66 13.29 91.6